Atlas Trials

Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen

Clinical trial NCT00016432 · COMPLETED

Trial details

NCT number
NCT00016432
Sponsor
NSABP Foundation Inc
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Breast Cancer
Start date
2001-05-01
Primary completion
2003-10-01
Enrollment
1598

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.